Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry

Amalgamated Bank Trims Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Defense World ·  {{timeTz}}

Amalgamated Bank lessened its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) by 4.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 90,794 shares of the company's stock after selling 3,910 shares during the period. Amalgamated Bank's holdings in Option Care Health were worth $2,593,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. State Street Corp boosted its position in Option Care Health by 3.0% during the 1st quarter. State Street Corp now owns 4,539,810 shares of the company's stock valued at $129,657,000 after acquiring an additional 133,504 shares in the last quarter. Bellevue Group AG boosted its position in Option Care Health by 10.6% during the 1st quarter. Bellevue Group AG now owns 3,232,787 shares of the company's stock valued at $92,328,000 after acquiring an additional 308,744 shares in the last quarter. Marshall Wace LLP bought a new stake in Option Care Health during the 4th quarter valued at approximately $85,991,000. Nuveen Asset Management LLC boosted its position in Option Care Health by 1.8% during the 4th quarter. Nuveen Asset Management LLC now owns 2,937,263 shares of the company's stock valued at $83,536,000 after acquiring an additional 53,279 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in Option Care Health by 7.1% during the 4th quarter. Geode Capital Management LLC now owns 2,688,710 shares of the company's stock valued at $76,466,000 after acquiring an additional 177,890 shares in the last quarter. Hedge funds and other institutional investors own 92.58% of the company's stock.

Get Option Care Health alerts:

Analyst Upgrades and Downgrades

Several analysts have weighed in on OPCH shares. Lake Street Capital lifted their price objective on Option Care Health from $35.00 to $45.00 in a research report on Thursday, July 28th. The Goldman Sachs Group lifted their price objective on Option Care Health from $31.00 to $40.00 and gave the company a "buy" rating in a research report on Monday, August 22nd. Barrington Research boosted their price target on Option Care Health from $33.00 to $37.00 and gave the stock an "outperform" rating in a research report on Thursday, July 28th. Finally, TheStreet raised Option Care Health from a "c+" rating to a "b" rating in a research report on Monday, June 6th.

Option Care Health Stock Performance

Shares of OPCH opened at $29.74 on Friday. The company has a quick ratio of 1.16, a current ratio of 1.58 and a debt-to-equity ratio of 0.82. The business's 50 day moving average price is $32.60 and its 200-day moving average price is $29.79. Option Care Health, Inc. has a 52 week low of $21.32 and a 52 week high of $35.57. The stock has a market cap of $5.41 billion, a P/E ratio of 30.66, a P/E/G ratio of 2.85 and a beta of 1.34.

Option Care Health (NASDAQ:OPCH – Get Rating) last released its quarterly earnings data on Wednesday, July 27th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.03). The business had revenue of $980.80 million during the quarter, compared to the consensus estimate of $940.93 million. Option Care Health had a net margin of 4.71% and a return on equity of 12.11%. The business's revenue was up 14.0% compared to the same quarter last year. During the same period last year, the company posted $0.18 earnings per share. Equities research analysts anticipate that Option Care Health, Inc. will post 0.78 earnings per share for the current fiscal year.

Insider Activity at Option Care Health

In related news, major shareholder Walgreens Boots Alliance, Inc. sold 11,000,000 shares of the company's stock in a transaction that occurred on Tuesday, August 16th. The stock was sold at an average price of $33.01, for a total value of $363,110,000.00. Following the transaction, the insider now directly owns 26,247,092 shares of the company's stock, valued at approximately $866,416,506.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Option Care Health news, Director R Carter Pate sold 1,923 shares of the business's stock in a transaction on Friday, July 8th. The shares were sold at an average price of $30.00, for a total transaction of $57,690.00. Following the completion of the sale, the director now directly owns 101,304 shares in the company, valued at approximately $3,039,120. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, major shareholder Walgreens Boots Alliance, Inc. sold 11,000,000 shares of the business's stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $33.01, for a total transaction of $363,110,000.00. Following the sale, the insider now owns 26,247,092 shares of the company's stock, valued at $866,416,506.92. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,003,846 shares of company stock valued at $363,231,861. 0.22% of the stock is owned by corporate insiders.

Option Care Health Profile

(Get Rating)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Further Reading

  • Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
  • Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Get Rating).

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.